Journals and Databases

Start a new search

Healthcare Databases Advanced Search | Help

 

Searched: Antiretroviral Therapy, Highly Active. Total records matched: 3067

Resources searched: MEDLINE from PubMed

  1. 1. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.

    Author(s): Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, Niyang M, Biadgilign S

    Citation: Journal of the International Association of Providers of AIDS Care, July 2014, vol./is. 13/4(346-52), 2325-9574

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  2. 2. Retraction: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

    Author(s): Ngemu EK, Khayeka-Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E

    Citation: BMC research notes, 25 November 2014(868),

    Publication Date: 25 November 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

  3. 3. Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy.

    Author(s): Sede M, Jones LR, Moretti F, Laufer N, Quarleri J

    Citation: Virology, 20 October 2014(19-28), 0042-6822

    Publication Date: 20 October 2014

    Source: MEDLINE from PubMed

  4. 4. Cardiac Steatosis and Left Ventricular Dysfunction in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy.

    Author(s): Nelson MD, Szczepaniak LS, LaBounty TM, Szczepaniak E, Li D, Tighiouart M, Li Q, Dharmakumar R, Sannes G, Fan Z, Yumul R, Hardy WD, Hernandez Conte A

    Citation: JACC. Cardiovascular imaging, November 2014, vol./is. 7/11(1175-7), 1936-878X

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  5. 5. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.

    Author(s): Chou CC, Tsai HC, Wu KS, Sy CL, Chen JK, Chen YS, Lee SS

    Citation: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 01 November 2014, 1684-1182

    Publication Date: 01 November 2014

    Source: MEDLINE from PubMed

  6. 6. Efficacy of generic highly active antiretroviral therapy in HIV-1 infected individuals in Nigeria.

    Author(s): Adewumi OM, Odaibo GN, Olaleye OD

    Citation: Journal of immunoassay & immunochemistry, 01 December 2014, 1532-1819

    Publication Date: 01 December 2014

    Source: MEDLINE from PubMed

  7. 7. HIV-1 Subtype Diversity Based on Envelope C2V3 Sequences from Kenyan Patients on Highly Active Antiretroviral Therapy.

    Author(s): Kitawi RC, Nzomo T, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Lwembe RM, Okendo J, Ogutu B, Ochieng W

    Citation: AIDS research and human retroviruses, 25 November 2014, 0889-2229

    Publication Date: 25 November 2014

    Source: MEDLINE from PubMed

  8. 8. HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy.

    Author(s): Costiniuk CT, Jenabian MA

    Citation: AIDS patient care and STDs, 20 November 2014, 1087-2914

    Publication Date: 20 November 2014

    Source: MEDLINE from PubMed

  9. 9. Apoptosis Pathways in HIV-1-Infected Patients Before and After Highly Active Antiretroviral Therapy: Relevance to Immune Recovery.

    Author(s): Pitrak DL, Novak RM, Estes R, Tschampa J, Abaya CD, Martinson J, Bradley K, Tenorio AR, Landay AL

    Citation: AIDS research and human retroviruses, 11 November 2014, 0889-2229

    Publication Date: 11 November 2014

    Source: MEDLINE from PubMed

  10. 10. Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor.

    Author(s): Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI, Sotomayor de Zavaleta M, Olvera-Posada D, Sierra-Madero JG, Arreguin-Camacho LO, Castillejos-Molina RA

    Citation: Sexual medicine, April 2014, vol./is. 2/1(24-30),

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  11. 11. Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review.

    Author(s): Katusiime C, Ocama P, Kambugu A

    Citation: African health sciences, September 2014, vol./is. 14/3(679-81), 1680-6905

    Publication Date: September 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  12. 12. Level of Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART).

    Author(s): Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP

    Citation: AIDS and behavior, 24 October 2014, 1090-7165

    Publication Date: 24 October 2014

    Source: MEDLINE from PubMed

  13. 13. The impact of comorbid clinical depression on the health-related quality of life of adults on highly active antiretroviral therapy in maiduguri, northeastern Nigeria.

    Author(s): Wakawa IA, Said JM, Abba WM, Shehu S, Rabbebe IB, Beida O

    Citation: Indian journal of psychological medicine, October 2014, vol./is. 36/4(408-17), 0253-7176

    Publication Date: October 2014

    Source: MEDLINE from PubMed

  14. 14. Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study.

    Author(s): Tesfaye Z, Enawgaw B

    Citation: BMC research notes, 22 October 2014(745),

    Publication Date: 22 October 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

  15. 15. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.

    Author(s): Bhutia E, Hemal A, Yadav TP, Ramesh KL

    Citation: African health sciences, June 2014, vol./is. 14/2(408-13), 1680-6905

    Publication Date: June 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  16. 16. Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria.

    Author(s): Onyedum CC, Young EE, Iroezindu MO, Chukwuka CJ, Nwagha UI

    Citation: Indian journal of endocrinology and metabolism, September 2014, vol./is. 18/5(631-6), 2230-8210

    Publication Date: September 2014

    Source: MEDLINE from PubMed

  17. 17. Influence of highly-active antiretroviral therapy on the subgingival biofilm in HIV-infected patients.

    Author(s): Jordan RA, Lucaciu A, Zimmer S

    Citation: Journal of investigative and clinical dentistry, 06 October 2014, 2041-1618

    Publication Date: 06 October 2014

    Source: MEDLINE from PubMed

  18. 18. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.

    Author(s): Duro M, Rebelo I, Barreira S, Sarmento-Castro R, Medeiros R, Almeida C

    Citation: International journal of STD & AIDS, 02 October 2014, 0956-4624

    Publication Date: 02 October 2014

    Source: MEDLINE from PubMed

  19. 19. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.

    Author(s): Ortega L, Cooper CJ, Otoukesh S, Mojtahedzadeh M, Didia CS, Torabi A, Nahleh Z

    Citation: Rare tumors, 30 July 2014, vol./is. 6/3(5480), 2036-3605

    Publication Date: 30 July 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  20. 20. Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy.

    Author(s): Carrico AW, Shoptaw S, Cox C, Stall R, Li X, Ostrow DG, Vlahov D, Plankey MW

    Citation: Journal of acquired immune deficiency syndromes (1999), 15 December 2014, vol./is. 67/5(508-13), 1525-4135

    Publication Date: 15 December 2014

    Source: MEDLINE from PubMed

  21. 21. Selected Micronutrient Levels and Response to Highly Active Antiretroviral Therapy (HAART) Among HIV/AIDS Patients Attending a Teaching Hospital in Addis Ababa, Ethiopia.

    Author(s): Eshetu A, Tsegaye A, Petros B

    Citation: Biological trace element research, December 2014, vol./is. 162/1-3(106-12), 0163-4984

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  22. 22. Changes in the Incidence of Severe Thrombocytopenia and Its Predisposing Conditions in HIV-Infected Patients Since the Introduction of Highly Active Antiretroviral Therapy.

    Author(s): Franzetti M, Adorni F, Oreni L, Van Den Bogaart L, Resnati C, Milazzo L, Antinori S, Galli M, Ridolfo AL

    Citation: Journal of acquired immune deficiency syndromes (1999), 15 December 2014, vol./is. 67/5(493-8), 1525-4135

    Publication Date: 15 December 2014

    Source: MEDLINE from PubMed

  23. 23. Vitamin E concentrations in adults with HIV/AIDS on highly active antiretroviral therapy.

    Author(s): Itinoseki Kaio DJ, Rondó PH, Luzia LA, Souza JM, Firmino AV, Santos SS

    Citation: Nutrients, 15 September 2014, vol./is. 6/9(3641-52),

    Publication Date: 15 September 2014

    Source: MEDLINE from PubMed

  24. 24. Virtual Elimination of Mother-to-Child Transmission of Human Immunodeficiency Virus in Mothers on Highly Active Antiretroviral Therapy in Enugu, South-Eastern Nigeria.

    Author(s): Okafor I, Ugwu E, Obi S, Odugu B

    Citation: Annals of medical and health sciences research, July 2014, vol./is. 4/4(615-8), 2141-9248

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  25. 25. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.

    Author(s): Zhyvytsia D

    Citation: Georgian medical news, July 2014(69-74), 1512-0112

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  26. 26. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.

    Author(s): Kyeyune R, Saathoff E, Ezeamama AE, Löscher T, Fawzi W, Guwatudde D

    Citation: BMC infectious diseases, 10 September 2014(496),

    Publication Date: 10 September 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

  27. 27. High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy.

    Author(s): Lumley S, Madge S, Nugent D, Ainsworth J, Dervisevic S, Schmitt C, Schulz TF, Johnson MA, Cwynarski K, Webster DP

    Citation: AIDS (London, England), 17 July 2014, vol./is. 28/11(1698-700), 0269-9370

    Publication Date: 17 July 2014

    Source: MEDLINE from PubMed

  28. 28. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy-era. A literature analysis.

    Author(s): Gaitán-Cepeda LA, Sánchez-Vargas O, Castillo N

    Citation: International journal of STD & AIDS, 25 August 2014, 0956-4624

    Publication Date: 25 August 2014

    Source: MEDLINE from PubMed

  29. 29. Adherence to highly active antiretroviral therapy and associated factors among children at the University of Gondar Hospital and Gondar Poly Clinic, Northwest Ethiopia: a cross-sectional institutional based study.

    Author(s): Dachew BA, Tesfahunegn TB, Birhanu AM

    Citation: BMC public health, 26 August 2014(875),

    Publication Date: 26 August 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

  30. 30. Magnetic resonance imaging evaluation of lipodystrophy in HIV-positive patients receiving highly active antiretroviral therapy.

    Author(s): Eichler K, Bickel T, Klauke S, Eisen J, Vogl T, Zangos S

    Citation: International journal of STD & AIDS, 18 August 2014, 0956-4624

    Publication Date: 18 August 2014

    Source: MEDLINE from PubMed

  31. 31. Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages.

    Author(s): Cribbs SK, Lennox J, Caliendo AM, Brown LA, Guidot DM

    Citation: AIDS research and human retroviruses, 11 September 2014, 0889-2229

    Publication Date: 11 September 2014

    Source: MEDLINE from PubMed

  32. 32. The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDS.

    Author(s): Zheng Y, Zhou H, He Y, Chen Z, He B, He M

    Citation: AIDS research and human retroviruses, December 2014, vol./is. 30/12(1197-202), 0889-2229

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  33. 33. Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: a systematic review and meta-analysis.

    Author(s): Liu H, Ma Y, Su Y, Smith MK, Liu Y, Jin Y, Gu H, Wu J, Zhu L, Wang N

    Citation: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 15 November 2014, vol./is. 59/10(1495-502), 1058-4838

    Publication Date: 15 November 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at Oxford University Press NHS Pilot 2014 (NESLi2); Note: ; Collection notes: Academic-License: Only available from an NHS networked computer

  34. 34. Body mass index changes during highly active antiretroviral therapy in Nigeria.

    Author(s): Denue BA, Ikunaiye PN, Denue CB

    Citation: Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 09 January 2014(S89-97), 1020-3397

    Publication Date: 09 January 2014

    Source: MEDLINE from PubMed

  35. 35. Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.

    Author(s): Li G, Liang S, Harrison TJ, Tang Z, Shen Z, Wang X, Wu X, Liu W, Liang F, Feng L, Yang J, Fang Z

    Citation: Intervirology, 2014, vol./is. 57/5(270-6), 0300-5526

    Publication Date: 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at Karger Medical and Scientific Publishers; Note: ; Collection notes: Academic-License: Only available from an NHS networked computer

  36. 36. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.

    Author(s): Gresele P, Falcinelli E, Momi S, Francisci D, Baldelli F

    Citation: Reviews in cardiovascular medicine, 2014(S9-20), 1530-6550

    Publication Date: 2014

    Source: MEDLINE from PubMed

  37. 37. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era.

    Author(s): D'Ascenzo F, Quadri G, Cerrato E, Calcagno A, Omedè P, Grosso Marra W, Abbate A, Bonora S, Biondi Zoccai G, Moretti C, Gaita F

    Citation: Journal of cardiovascular medicine (Hagerstown, Md.), 28 June 2014, 1558-2027

    Publication Date: 28 June 2014

    Source: MEDLINE from PubMed

  38. 38. A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART).

    Author(s): Lertcheewakarn P, Tongprasert F

    Citation: Journal of the Medical Association of Thailand = Chotmaihet thangphaet, April 2014, vol./is. 97/4(361-8), 0125-2208

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  39. 39. Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy.

    Author(s): Bosamiya SS, Vaishnani JB, Momin AM

    Citation: Indian journal of sexually transmitted diseases, January 2014, vol./is. 35/1(73-5), 0253-7184

    Publication Date: January 2014

    Source: MEDLINE from PubMed

  40. 40. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study.

    Author(s): Tadesse WT, Mekonnen AB, Tesfaye WH, Tadesse YT

    Citation: BMC pharmacology & toxicology, 23 June 2014(32),

    Publication Date: 23 June 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at BioMedCentral

  41. 41. Impacts of highly active antiretroviral therapy (HAART) on metabolic status of patients with AIDS: What happens from the initiation of AIDS to the initiation of treatment?

    Author(s): Abdollahi A, Shoar S, Jafari S, Shoar N

    Citation: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, March 2014, vol./is. 19/3(246-50), 1735-1995

    Publication Date: March 2014

    Source: MEDLINE from PubMed

  42. 42. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting.

    Author(s): Nugent J, Edmonds A, Lusiama J, Thompson D, Behets F

    Citation: The Pediatric infectious disease journal, November 2014, vol./is. 33/11(1148-55), 0891-3668

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  43. 43. Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South Nigeria.

    Author(s): Ikpeme EE, Etukudo OM, Ekrikpo UE

    Citation: African health sciences, December 2013, vol./is. 13/4(955-61), 1680-6905

    Publication Date: December 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  44. 44. Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria.

    Author(s): Afolabi BA, Afolabi MO, Afolabi AA, Odewale MA, Olowookere SA

    Citation: African health sciences, December 2013, vol./is. 13/4(920-6), 1680-6905

    Publication Date: December 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  45. 45. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.

    Author(s): Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, Zhang L, Liu Z, Liang H, Tao R

    Citation: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, October 2014, vol./is. 43/9(696-703), 0904-2512

    Publication Date: October 2014

    Source: MEDLINE from PubMed

  46. 46. Renal function in Ghanaian HIV-infected patients on highly active antiretroviral therapy: a case-control study.

    Author(s): Obirikorang C, Osakunor DN, Ntaadu B, Adarkwa OK

    Citation: PloS one, 2014, vol./is. 9/6(e99469),

    Publication Date: 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  47. 47. Response to letter 'Poor citation, coding and reporting: a review of adherence-enhancing interventions for highly active antiretroviral therapy creates an inaccurate picture of the state of the field'.

    Author(s): Mathes T, Pieper D, Antoine SL, Eikermann M

    Citation: HIV medicine, July 2014, vol./is. 15/6(383-4), 1464-2662

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  48. 48. Poor citation, coding and reporting: a review of adherence-enhancing interventions for highly active antiretroviral therapy creates an inaccurate picture of the state of the field.

    Author(s): de Bruin M, Simoni J, Amico KR, Parsons JT, Fisher J, Safren SA

    Citation: HIV medicine, July 2014, vol./is. 15/6(381-2), 1464-2662

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  49. 49. Highly active antiretroviral therapy during gestation: effects on a rat model of pregnancy.

    Author(s): F CL, Simões RS, Araujo Júnior Corresponding Author E, Oliveira Filho RM, Kulay Júnior L, Nakamura MU

    Citation: Ceska gynekologie / Ceska lekarska spolecnost J. Ev. Purkyne, April 2014, vol./is. 79/2(128-33), 1210-7832

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  50. 50. Autonomic neuropathy resulting in recurrent laryngeal nerve palsy in an HIV patient with Hodgkin lymphoma receiving vinblastine and highly active antiretroviral therapy.

    Author(s): Cherif S, Danino S, Yoganathan K

    Citation: International journal of STD & AIDS, 14 May 2014, 0956-4624

    Publication Date: 14 May 2014

    Source: MEDLINE from PubMed


Results Selected
No results selected.

Output Format
Choose output document format.
Display Format
Choose output fields.
Actions
Display, save or email results with selected fields and output formats.